United States Automated Hematology Analyzer Market 2026 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth 2026

DataM Intelligence has released a new research report titled Automated Hematology Analyzer Market Size 2026 The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Automated Hematology Analyzer market.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/automated-hematology-analyzer-market?sb

Key Developments 2025-2026:

United States: Recent Industry Developments

✅ In July 2026, Sysmex America showcased its new XR-1000 and XR-9000 hematology solutions at ADLM 2026. The XR-1000 can process up to 110 samples per hour, while the XR-9000 provides a scalable, modular solution for high-volume laboratories, increasing throughput and reducing manual touchpoints.

✅ In May 2026, Sysmex America introduced its next-generation XR-Series Automated Hematology Solution for clinical laboratories. The platform adds higher throughput, enhanced analytics and 3D scattergram technology, while the XR-20 also offers an optional WPC channel to improve cell differentiation and result interpretation.

✅ In May 2026, Sysmex expanded its hematology automation portfolio with the XR-Series, designed to provide approximately 10% higher throughput than the XN-Series. The platform combines reformulated reagents, advanced parameters and enhanced analytics while maintaining a familiar workflow for existing users.

Japan: Recent Industry Developments

✅ In August 2026, Sysmex was selected for Japan's FY2026 international medical technology program to expand automated anemia and malaria testing in Kenya. Its XN-31 analyzer can automatically detect malaria-infected red blood cells in approximately one minute while simultaneously measuring eight CBC parameters.

✅ In August 2026, Sysmex expanded the clinical applications surrounding its automated laboratory portfolio by launching HISCL ADAMTS13 Activity Reagent for the diagnosis support of thrombotic thrombocytopenic purpura (TTP). The reagent is designed for use with the fully automated CN-6500 and CN-3500 systems, strengthening automated blood-related testing capabilities.

✅ In July 2026, Sysmex highlighted its next-generation hematology automation technologies alongside its broader laboratory automation portfolio at ADLM 2026. The company's XR-Series combines higher throughput, advanced analytics and 3D scattergram technology to support more efficient and standardized hematology workflows.

Ready to scale in the Automated Hematology Analyzer Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/automated-hematology-analyzer-market?sb

List of Key Players 2026:

=> Beckman Coulter, Inc., Accurex, Sysmex, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Abbott, HORIBA Group, Biobase Biodusty(Shandong), Co., Ltd., Erba Group, Labtron Equipment Ltd., Trivitron Healthcare, among others.

Growth Forecast Projection 2026:

The Global Automated Hematology Analyzer Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

How Our Market Research Process Works:

The global Automated Hematology Analyzer Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Automated Hematology Analyzer ecosystem.

Request Strategic Market Customization: https://datamintelligence.com/customize/automated-hematology-analyzer-market?sb

Major Focused Key Segmentations 2026:

By Type

5-Part Differential Hematology Analyzers lead with 52% share, driven by their ability to provide detailed white blood cell differentiation, higher analytical accuracy, and broad adoption in hospitals and diagnostic laboratories. 3-Part Differential Hematology Analyzers account for 32%, supported by their affordability, simpler operation, and suitability for routine blood testing in smaller laboratories and healthcare facilities. Advanced Analyzers hold 16%, supported by increasing demand for high-throughput testing, automation, advanced parameters, and integrated laboratory workflows.

By Application

Diagnostic Testing dominates with 55% share, driven by the widespread use of hematology analyzers for complete blood counts and routine diagnosis of anemia, infections, blood disorders, and other conditions. Blood Screening accounts for 18%, supported by growing blood safety requirements and screening activities in blood banks and transfusion centers. Treatment Monitoring represents 14%, driven by the need to monitor patients undergoing treatment for hematological and chronic diseases. Research and Development holds 8%, supported by clinical research, drug development, and hematological studies. Others account for 5%, including preventive health screening and specialized testing.

By End-User

Hospitals hold the largest share at 48%, supported by high patient volumes, comprehensive diagnostic services, and increasing adoption of automated laboratory systems. Clinical Laboratories account for 38%, driven by growing diagnostic testing volumes, centralized laboratory operations, and demand for rapid and accurate blood analysis. Academic and Research Institutes represent 9%, supported by hematology research, clinical studies, and technology development. Others contribute 5%, including blood banks, specialty diagnostic centers, and healthcare facilities.

Regional Analysis (By Region)

North America - 36% Share

North America leads with 36% share, supported by advanced healthcare infrastructure, high diagnostic testing volumes, widespread laboratory automation, and strong adoption of sophisticated hematology analyzers. The region also benefits from established clinical laboratories and continued investment in advanced diagnostic technologies.

Europe - 29% Share

Europe accounts for 29%, driven by well-developed healthcare systems, increasing demand for automated diagnostics, and strong emphasis on early disease detection. Modernization of clinical laboratories and adoption of high-throughput testing technologies further support market growth.

Asia-Pacific - 25% Share

Asia-Pacific holds 25%, supported by expanding healthcare infrastructure, increasing diagnostic testing, large patient populations, and growing investments in laboratory automation. China, Japan, India, South Korea, and other emerging markets are contributing to rising adoption of automated hematology analyzers.

South America - 6% Share

South America represents 6%, driven by improving healthcare infrastructure, increasing access to diagnostic services, and growing investments in automated laboratory equipment. Expansion of hospitals and private diagnostic laboratories is creating additional demand.

Middle East & Africa - 4% Share

The Middle East & Africa accounts for 4%, supported by healthcare infrastructure development, increasing diagnostic capacity, government healthcare investments, and growing awareness of early disease detection. Adoption is expected to increase as laboratories modernize and access to advanced diagnostic technologies improves.

Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=automated-hematology-analyzer-market?sb

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

FAQ

Q1: What is the current size of the Automated Hematology Analyzer Market?

A: The Automated Hematology Analyzer Market was valued at US$ 504.00 million in 2024 and is forecasted to hit US$ 960.51 million by 2033

Q2: How rapidly will the Market expanding?

A: The Automated Hematology Analyzer market is projected to grow at a CAGR of 8.4% between 2026 and 2033.

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?sb

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.